Polycystin-2 is regulated by endoplasmic reticulum-associated degradation

Area of Science:

• Cell Biology
• Molecular Biology
• Biochemistry

Background:

• Endoplasmic reticulum-associated degradation (ERAD) is vital for cellular protein quality control.
• Misfolded proteins are targeted for degradation via the ubiquitin-proteasome system.
• Polycystin-2 (PC2) mutations cause autosomal dominant polycystic kidney disease (ADPKD), but mechanisms are unclear.

Purpose of the Study:

• To investigate the role of ERAD in regulating PC2 protein levels.
• To elucidate the molecular mechanisms linking PC2 to ERAD.
• To determine if ERAD dysfunction contributes to ADPKD.

Main Methods:

• Co-immunoprecipitation assays to detect protein interactions.
• Western blotting to assess protein degradation rates.
• Expression analysis of ERAD components under ER stress conditions.

Main Results:

• PC2 interacts with ERAD components p97 and Herp.
• Herp is required for and promotes PC2 degradation.
• ER stress enhances PC2 degradation via increased Herp expression.
• Pathogenic PC2 mutants (R872X, E837X) are degraded by ERAD when interacting with Herp.

Conclusions:

• PC2 is a novel substrate of the ERAD pathway.
• Herp plays a key role in PC2 degradation.
• ERAD pathway alterations due to PC2 mutations may contribute to ADPKD pathogenesis.